Insmed Incorporated Insmed Incorporated

Insmed Incorporated

INSM

Classement en actions #1110
Insmed Incorporated operates as a biopharmaceutical enterprise focused on... Insmed Incorporated operates as a biopharmaceutical enterprise focused on creating and introducing medical solutions for individuals facing severe and uncommon health conditions. The company's marketed treatment, ARIKAYCE, is administered to adult patients suffering from Mycobacterium avium complex (MAC) lung disease, serving as a component of a broader antibacterial drug regimen. In its development pipeline, Insmed is advancing Brensocatib, an oral and reversible inhibitor targeting dipeptidyl peptidase 1, which is being investigated for its potential in treating bronchiectasis and other disorders mediated by neutrophils. Additionally, the firm is developing Treprostinil Palmitil Inhalation Powder, an inhaled version of the treprostinil palmitil prodrug, designed to address pulmonary arterial hypertension and various other rare lung ailments. Founded in 1988, Insmed Incorporated maintains its primary corporate offices in Bridgewater, New Jersey.
Prix de l'action
$95.88
Dernière synchronisation: 2026-10-20
Capitalisation boursière
$20.94B
Changement (1 jour)
0.61%
Changement (1 an)
-42.00%
Pays
US
Échange Insmed Incorporated (INSM)

Catégorie

Healthcare
Historique des divisions d’actions pour Insmed Incorporated (INSM)
L’action Insmed Incorporated (symbole : INSM) a subi un total de 2 divisions.
La division la plus récente a eu lieu le Mar 03, 2011.
Une action INSM achetée avant le Jul 31, 2000 équivaudrait aujourd’hui à 0.025 actions INSM.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
2011-03-03 1:10 x0.1 x0.025
2000-07-31 1:4 x0.25 x0.25
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
1 x2
US
0 -
US
1 x3
AU
0 -
CH
0 -
NL